1 February 2019 - The February 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.
There is one major new listing this month; glecaprevir with pibrentasvir (Maviret) for patients with chronic hepatitis C virus infection.
Read New Zealand Pharmaceutical Schedule update